Salta al contenido principal
Para continuar usando este sitio web, debe aceptar nuestras políticas:
  • Politique de confidentialité
Continuar
x
eCampus
  • Página Principal
  • Ressources
    Tutoriels enseignants Portfolio Mahara Wooclap eMedia
  • Más
Español - Internacional ‎(es)‎
English ‎(en)‎ Español - Internacional ‎(es)‎ Français ‎(fr)‎
En este momento está usando el acceso para invitados
Acceder
eCampus
Página Principal Ressources Colapsar Expandir
Tutoriels enseignants Portfolio Mahara Wooclap eMedia
Expandir todo Colapsar todo
  1. Área personal
  2. M1 D2HP 24-25
  3. TU 08: Biotechnology (S1)
  4. Quality Control of therapeutic proteins

Quality Control of therapeutic proteins

Requisitos de finalización
    • acidic and basic variants analysis of monoclonal antibodies by IEX-HPLC acidic and basic variants analysis of monoclonal antibodies by IEX-HPLC
      • Agilent publication 2.pdf Agilent publication 2.pdf
      • Bai et al., 2000.pdf Bai et al., 2000.pdf
      • fekete 2015.pdf fekete 2015.pdf
      • SUPPOR~1.PPT SUPPOR~1.PPT
      • zhang2013.pdf zhang2013.pdf
    • Capillary Gel electrophoresis for identity and purity control of therapeutic proteins Capillary Gel electrophoresis for identity and purity control of therapeutic proteins
      • Bhimwal et al., 2022.pdf Bhimwal et al., 2022.pdf
      • ce-SDS-analysis-therapeutic-proteins.pdf ce-SDS-analysis-therapeutic-proteins.pdf
      • Hajba et al., 2023 from page 1 to 5.pdf Hajba et al., 2023 from page 1 to 5.pdf
      • IntroductiontoCapillaryElectrophoresisVol-I page 21.pdf IntroductiontoCapillaryElectrophoresisVol-I page 21.pdf
      • SUPPORTING SLIDES - ORAL PRESENTATION- CGE-2024.pptx SUPPORTING SLIDES - ORAL PRESENTATION- CGE-2024.pptx
    • control of secondary Structure of therapeutic proteins control of secondary Structure of therapeutic proteins
      • AN52985-protein-secondary-structure-elucidation-FTIR-spectroscopy.pdf AN52985-protein-secondary-structure-elucidation-FTIR-spectroscopy.pdf
      • cerasolini 2014-Temperature denaturation and aggregation of a multi-domain IGG by biophysical methods.pdf cerasolini 2014-Temperature denaturation and aggregation of a multi-domain IGG by biophysical methods.pdf
      • Siligardi-Hussain2015_Protocol_CDSpectroscopyAnEssentialToolF.pdf Siligardi-Hussain2015_Protocol_CDSpectroscopyAnEssentialToolF.pdf
      • SUPPORTING SLIDES - ORAL PRESENTATION- Circular dichroism 2024.pptx SUPPORTING SLIDES - ORAL PRESENTATION- Circular dichroism 2024.pptx
    • Detection of chemical-degradation variants of therapeutic proteins by RP-HPLC Detection of chemical-degradation variants of therapeutic proteins by RP-HPLC
      • AmershamRPCManual RP HPLC Theory.pdf AmershamRPCManual RP HPLC Theory.pdf
      • Fagan 2024.pdf Fagan 2024.pdf
      • kim 2015.pdf kim 2015.pdf
      • lorbetskie 2022.pdf lorbetskie 2022.pdf
      • SUPPORTING SLIDES - ORAL PRESENTATION- RP-HPLC- 2024 (1).pptx SUPPORTING SLIDES - ORAL PRESENTATION- RP-HPLC- 2024 (1).pptx
    • N-glycan mapping of therapeutic glycoproteins by HILIC-HPLC N-glycan mapping of therapeutic glycoproteins by HILIC-HPLC
      • kmab-glycan analysis of therapeutic proteins- Zhang L 2016.pdf kmab-glycan analysis of therapeutic proteins- Zhang L 2016.pdf
      • Planinc 2016-ACA-Glycan characterization of biopharmaceuticals-Updates and perspectives.pdf Planinc 2016-ACA-Glycan characterization of biopharmaceuticals-Updates and perspectives.pdf
      • SUPPORTING SLIDES FOR PREPARING THE ORAL PRESENTATION- Glycan profiling 2024.pptx SUPPORTING SLIDES FOR PREPARING THE ORAL PRESENTATION- Glycan profiling 2024.pptx
    • Peptide mapping of therapeutic proteins by RP-HLC as an identity control Peptide mapping of therapeutic proteins by RP-HLC as an identity control
      • bobaly et al., 2017.pdf bobaly et al., 2017.pdf
      • Bongers et al., 2000.pdf Bongers et al., 2000.pdf
      • focus on peptide mapping , analytical condition and mechanism.pdf focus on peptide mapping , analytical condition and mechanism.pdf
      • Garnik et al., 1988.pdf Garnik et al., 1988.pdf
      • SUPPORTING SLIDES - ORAL PRESENTATION- peptide mapping 2024.pptx SUPPORTING SLIDES - ORAL PRESENTATION- peptide mapping 2024.pptx
    • Purity control of therapeutic proteins by size exclusion chromatography (SEC-HPLC) Purity control of therapeutic proteins by size exclusion chromatography (SEC-HPLC)
      • berkowitz2020.pdf berkowitz2020.pdf
      • Biopharmaceuticals - SEC.pdf Biopharmaceuticals - SEC.pdf
      • Fekete 2014.pdf Fekete 2014.pdf
      • hall2018.pdf hall2018.pdf
      • SUPPOR~1.PPT SUPPOR~1.PPT
    • SDS-PAGE for purity and identity controls of therapeutic proteins SDS-PAGE for purity and identity controls of therapeutic proteins
      • reichel et al., 2013.pdf reichel et al., 2013.pdf
      • roy kumar 2014.pdf roy kumar 2014.pdf
      • SILVAE~1.PDF SILVAE~1.PDF
      • SUPPORTING SLIDES - ORAL PRESENTATION- SDS 2024 (1).pptx SUPPORTING SLIDES - ORAL PRESENTATION- SDS 2024 (1).pptx
    • QC biopharmaceuticals -M1-2024-MT3-17 oct 2024.pdf QC biopharmaceuticals -M1-2024-MT3-17 oct 2024.pdf
    • separation methods -brief summary.pdf separation methods -brief summary.pdf
◄ Examples of exam
documents ►
En este momento está usando el acceso para invitados (Acceder)
Políticas
Descargar la app para dispositivos móviles
Desarrollado por Moodle
  • Validar HTML
  • Comprobación de Pautas de accesibilidad al contenido web (WCAG)

eCampus

Université Paris-Saclay 7
  • UPSaclay
  • UEVE
  • UVSQ
  • Centrale Supélec
  • École Normale Supérieure
  • Institut d'Optique
  • AgroParisTech
Institut Polytechnique de Paris 3
  • ENSTA
  • Télécom Paris

European University Alliance for Global Health (EUGLOH)
  •  


Actualités